Evidence map›Paper›PMID 31907773›Full record

ArticleDigestive diseases and sciences2020

Severity of Ascites Is Associated with Increased Mortality in Patients with Cirrhosis Secondary to Biliary Atresia.

Renata R Guedes, Carlos O Kieling, Jorge L Dos Santos, Carolina da Rocha, Fernando Schwengber, Marina R Adami, Marcio F Chedid, Sandra M G Vieira

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Renata R GuedesPediatric Liver Transplantation Unit, Pediatric Service, Hospital de Clínicas de Porto Alegre, Postgraduation Program in Gastroenterology and Hepatology Sciences, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2350, Sala 1143, Porto Alegre, RS, 90035-903, Brazil. rguedes@hcpa.edu.br.ORCID 0000-0001-6634-1391
Carlos O KielingPediatric Liver Transplantation Unit, Pediatric Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, Sala 1143, Porto Alegre, RS, 90035-903, Brazil.
Jorge L Dos SantosHealth Science Research Centre, University of Beira Interior (CICS, UBI), Universidade da Beira Interior, R. Marquês de Ávila e Bolama, 6201-001, Covilhã, Portugal.
Carolina da RochaPediatric Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, Sala 1045, Porto Alegre, RS, 90035-903, Brazil.
Fernando SchwengberInternal Medicine Service, Hospital de Clínicas de Porto Alegre, Rua Corte Real 82, Porto Alegre, RS, 90630-080, Brazil.
Marina R AdamiPediatric Liver Transplantation Unit, Pediatric Service, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, Sala 1143, Porto Alegre, RS, 90035-903, Brazil.
Marcio F ChedidPostgraduation Program in Surgical Sciences, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2350, Sala 743, Porto Alegre, RS, 90035-903, Brazil.
Sandra M G VieiraPediatric Liver Transplantation Unit, Pediatric Service, Hospital de Clínicas de Porto Alegre, Postgraduation Program in Gastroenterology and Hepatology Sciences, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2350, Sala 1143, Porto Alegre, RS, 90035-903, Brazil.
Hospital de Clínicas de Porto Alegre · BRUniversidade Federal do Rio Grande do Sul · BRUniversity of Beira Interior · PT

Funding

Hospital de Clínicas de Porto Alegre Fundo de Incentivo à Pesquisa e Eventos do Hospital de Clínicas de Porto Alegre (FIPE)
6 · The paper itself

Abstract

backgroundVery few prior studies have investigated the presence of ascites as a prognostic factor in children with cirrhosis. To the best of our knowledge, there are no prior studies evaluating the relationship between severity of ascites and patient survival in children with biliary atresia and cirrhosis.

aimsTo evaluate the association between severity of ascites and survival of children with cirrhosis and biliary atresia.

methodsAll children with cirrhosis secondary to biliary atresia evaluated at our institution from 2000 to 2014 were included in this study. Patients were classified into four groups: NA = no ascites; A1 = grade 1 ascites; A2 = grade 2 ascites; and A3 = grade 3 ascites. The primary endpoint of the study was mortality within the first year after patient inclusion. Ninety-day mortality was also evaluated. Prognostic factors related to both endpoints also were studied.

resultsOne-year patient survival for NA was 97.1%, versus 80.8% for A1, versus 52% for A2, versus 13.6 for A3 (p < 0.001). The presence of ascites increased mortality by 17 times. In the multivariate analysis, clinically detectable ascites (HR 3.14, 95% CI 1.14-8.60, p = 0.026), lower sodium (HR 1.15, 95% CI 1.04-1.27, p = 0.006), higher bilirubin (HR 1.06, 95% CI 1.00-1.12, p = 0.023), and higher PELD score (HR 1.05, 95% CI 1.02-1.08, p = 0.001) were all associated with decreased survival. Lower serum sodium (HR 1.20, 95% CI 1.09-1.32, p < 0.001) and higher PELD score (HR 1.03, 95% CI 1.001-1.063, p = 0.043) were associated with increased 90-day mortality.

conclusionsClinically detectable ascites is associated with decreased 1-year survival of children with biliary atresia. These patients should be treated with caution and prioritized for liver transplantation.

Indexed as

AscitesBiliary AtresiaBrazilChildChild, PreschoolFemaleHumansInfantLiver CirrhosisMalePrognosisRetrospective StudiesRisk FactorsSeverity of Illness IndexSurvival AnalysisAscitesChronic liver diseaseLiver transplantPediatric patientsPortal hypertensionSurvival

Identifiers

PMID31907773
OpenAlexW2999401851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.